Background Metastatic triple-negative breast cancer (mTNBC) is treated mainly with
chemotherapy. However, resistance frequently occurs as tumours enter dormancy. Statins have …

Amino-bisphosphonates such as zoledronic acid (ZA) can possibly ameliorate or prevent
severe COVID-19 disease by at least three distinct mechanisms: (1) as immunostimulants …

Background As the implementation of trastuzumab, several studies have investigated new
agents and regimens to treat human epidermal growth factor 2-positive (HER2+) metastatic …

Zinc (Zn) inhibits SARS-CoV-2 in vitro by several different mechanism. Zn deficiency may
increase the risk for severity of COVID-19 infection. The addition of Zn, particularly with a Zn …

SARS‐CoV‐2 triggers a dysregulated innate immune system activation. As the mevalonate
pathway (MVP) prevents the activation of inflammasomes and cytokine release and …

Opinion statement The management of patients with HER2+ breast cancer has evolved
significantly over the preceding decades. HER2 targeting strategies have advanced beyond …

Most breast cancers are hormone-receptor positive (HR+). However, more women eventually
die from HR+ breast cancer than from either HER2+ or triple negative breast cancer. …

Background: Incidence of breast cancer (BC) in US women continues to increase with age
as the strongest risk factor. We aimed to compare clinical, pathological and sociological …

Limitations in timely testing for SARS-CoV-2 drive the need for new approaches in
suspected COVID-19 disease. We queried whether viral load (VL) in the upper airways at …

Simple Summary Breast cancer is the most frequently diagnosed cancer and second
leading cause of cancer-related death among women worldwide. After initial tumor resection, …